Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Licensing
27 Articles Available
0
2
Can't find what you're looking for? Try our
advanced search
.
Patented Production Strains
Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains
PAO-08-022-CL-03
Licensing
AstraZeneca Completes Recovery of Global Rights to Brazikumab from Allergan
PR-M05-20-NI-019
Licensing
LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
PR-M04-20-NI-023
Licensing and Partnering
Facilitating Pharma Licensing and Partnering
PAP-Q1-20-CL-026
Legality
Legal Issues in Licensing and M&A
PAP-Q1-20-CL-028
Licensing
Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
PR-M02-20-NI-027
License Agreement
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
PR-M10-19-NI-046
Licensing Agreement
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX
PR-M10-19-NI-020
Licensing
Ionis Licenses Hepatitis B Program to GSK
PR-M08-19-NI-085
Licensing
Harbour BioMed Enters Multi-Year HCAb Technology Licensing Agreement with a Top-Ten Global Pharma for Next Generation Human Antibody Discovery
PR-M05-19-NI-088
Collaboration
Lilly and ImmuNext Announce Licensing and Research Collaboration
PR-M03-19-NI-086
Immuno-Oncology
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million
PR-M02-19-NI-067
Drug Development
AbbVie Exercises Option to License Parkinson’s Tech from BioArctic
PAO-M12-18-NI-015
License Agreement
Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard
PR-M09-18-NI-067
Growth Strategy
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®
PR-M08-18-NI-117
FDA Approval
Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
PR-M05-18-NI-058
Licensing
Merck Projected to Spend the Most on Licensing Deals in 2018
PAO-M04-18-NI-003
Licensing
Protein Science to Advance Through LenioBio and Dow AgroSciences License Agreement
PR-M03-18-NI-064
Biosimilar
Mylan to Bring a Biosimilar of BOTOX to the Market Through a Collaboration and License agreement with Revance Therapeutics
PR-M03-18-NI-017
License Agreement
Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates
PR-M03-18-NI-009
Drug Development
Kidney Disease Drug Licensed to AstraZeneca
PAO-M02-18-NI-022
Licensing
Oxford BioMedica Completes Licensing Agreement with Bioverativ Inc.
PAO-M02-18-NI-019
Licensing
Grace Licenses UNIPOL® PP Process Technology to Grupa Azoty in Poland
PR-M01-18-NI-090
Licensing Agreement
Generex Biotech and Shenzhen BioScien Enter into Licensing Agreement
PAO-M01-18-NI-014
«
0
2
»
